These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12143238)

  • 1. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
    Kim YW; Park YK; Yoon TY; Lee SM
    Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
    da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
    Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis.
    Hui AM; Li X; Shi YZ; Torzilli G; Takayama T; Makuuchi M
    Hepatology; 2000 May; 31(5):1068-72. PubMed ID: 10796881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
    Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
    Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
    Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.
    Sung JY; Kim GY; Lim SJ; Park YK; Kim YW
    Pathol Res Pract; 2010 Jan; 206(1):24-9. PubMed ID: 19819644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
    Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
    Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preneoplastic lesions in gallbladder cancer.
    Roa I; de Aretxabala X; Araya JC; Roa J
    J Surg Oncol; 2006 Jun; 93(8):615-23. PubMed ID: 16724345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P; Marchegiani C; Capella C; Sessa F
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
    Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
    Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
    Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
    Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
    J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
    Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
    Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
    Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis.
    Chang HJ; Jee CD; Kim WH
    Am J Surg Pathol; 2002 Jun; 26(6):758-66. PubMed ID: 12023580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
    Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
    Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
    Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.